Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 225 of 306 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 09/08/15
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 11/10/21
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 03/07/15
Due: 03/07/16
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 03/01/19
Due: 03/01/20
Opioid-Sparing Protocol Comparing With Opioid-based Protocol After Bilateral Total Knee Arthroplasty
Phase: N/A
Priority: Normal
Start: 03/20/20
End: 08/20/20
Due: 08/20/21
Phase: N/A
Priority: Normal
Start: 11/10/20
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 12/01/21
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 08/12/22
End: 02/21/23
Due: 02/21/24
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 11/16/17
Due: 11/16/18
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 05/31/21
Due: 05/31/22
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 02/26/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 06/30/14
Due: 06/30/15